In Brief Ruth O’Regan named chief scientific officer of Big Ten Cancer Research Consortium October 05, 2018Vol.44 No.37
In Brief Peter Wiklund named director of the Bladder Cancer Program at Mount Sinai October 05, 2018Vol.44 No.37
In Brief 2018 NIH Director’s awards for high-risk, high-reward research program announced October 05, 2018Vol.44 No.37
In Brief Queen’s University Belfast and the University of Leeds researchers win the 2018 European Health Award October 05, 2018Vol.44 No.37
In Brief Shirley Mertz elected chair and Christine Benjamin vice chair of Metastatic Breast Cancer Alliance October 05, 2018Vol.44 No.37
Conversation with The Cancer Letter Roy Jensen: “In general, I think cancer center directors still enjoy a certain amount of respect” October 05, 2018Vol.44 No.37By Paul Goldberg
Craig Thompson resigns from two corporate boards as MSK crisis shifts to board roles October 05, 2018Vol.44 No.37By Paul Goldberg
Drugs & Targets European Commission approves Braftovi + Mektovi for advanced BRAF-mutant melanoma September 21, 2018Vol.44 No.35
Drugs & Targets OBI Pharma granted Orphan Drug Designation for treatment of ALL September 21, 2018Vol.44 No.35
